Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Luca Gregoletto"'
Autor:
Francesca Oltolina, Andrea Zamperone, Donato Colangelo, Luca Gregoletto, Simone Reano, Stefano Pietronave, Simone Merlin, Maria Talmon, Eugenio Novelli, Marco Diena, Carmine Nicoletti, Antonio Musarò, Nicoletta Filigheddu, Antonia Follenzi, Maria Prat
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0141632 (2015)
Externí odkaz:
https://doaj.org/article/472113c6ed77489685675cdcfa747374
Autor:
Francesca Oltolina, Andrea Zamperone, Donato Colangelo, Luca Gregoletto, Simone Reano, Stefano Pietronave, Simone Merlin, Maria Talmon, Eugenio Novelli, Marco Diena, Carmine Nicoletti, Antonio Musarò, Nicoletta Filigheddu, Antonia Follenzi, Maria Prat
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137999 (2015)
A major obstacle to an effective myocardium stem cell therapy has always been the delivery and survival of implanted stem cells in the heart. Better engraftment can be achieved if cells are administered as cell aggregates, which maintain their extra-
Externí odkaz:
https://doaj.org/article/2224d588b376464e80bba0f141f76867
Autor:
Luca Gregoletto, José Manuel Delgado-López, Maria Prat, Jaime Gómez-Morales, Donato Colangelo, Francesca Oltolina
Publikováno v:
Langmuir. 31:1766-1775
Multifunctional biomimetic nanoparticles (NPs) are acquiring increasing interest as carriers in medicine and basic research since they can efficiently combine labels for subsequent tracking, moieties for specific cell targeting, and bioactive molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e615d569da50cdfa4eeae9e4a28ab15
https://doi.org/10.1021/la503747s
https://doi.org/10.1021/la503747s
Autor:
Simone Reano, Francesca Oltolina, Maria Talmon, Antonio Musarò, Nicoletta Filigheddu, Carmine Nicoletti, Antonia Follenzi, Andrea Zamperone, Luca Gregoletto, Donato Colangelo, Marco Diena, Maria Prat, Stefano Pietronave, Eugenio Novelli, Simone Merlin
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137999 (2015)
PLoS ONE
PLoS ONE
A major obstacle to an effective myocardium stem cell therapy has always been the delivery and survival of implanted stem cells in the heart. Better engraftment can be achieved if cells are administered as cell aggregates, which maintain their extra-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07c61bf596bfd60809ab894654a7d3f3
https://doi.org/10.1371/journal.pone.0137999
https://doi.org/10.1371/journal.pone.0137999